Validated Assays of the UCSD Clinical Pharmacology and Assay Laboratory
Table 1: Antiviral Drugs
Nucleoside Reverse Transcriptase Inhibitors (NRTI) |
ABC | 0.041 | Abacavir (Ziagen®) |
ddI | 0.010 | Didanosine (Videx®) |
FTC | 0.013 | Emtricitabine (Emtriva®) |
3TC | 0.031 | Lamivudine (Epivir®) |
TDF | 0.013 | Tenofovir disoproxil fumarate (Viread®) |
ZDV (AZT) | 0.010 | Zidovudine (Retrovir®) |
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTI) |
EFV | 0.048 | Efavirenz (Sustiva®) |
NVP | 0.043 | Nevirapine (Viramune®) |
Protease Inhibitors (PI) |
APV | 0.156 | Amprenavir (Agenerase®) |
APV-L | 0.156 | Fosamprenavir (Lexiva™) |
ATV | 0.045 | Atazanavir (Reyataz™) |
IDV | 0.039 | Indinavir (Crixivan®) |
LPV/r | 0.048 | Lopinavir/ritonavir (Kaletra®) |
NFV | 0.039 | Nelfinavir (Viracept®) |
M8 | 0.039 | Nelfinavir metabolite |
RTV | 0.059 | Ritonavir (Norvir®) |
SQV | 0.040 | Saquinavir (Invirase®) |